Health technology appraisals in the UK will use higher cost-effectiveness thresholds from April 2026 to help accommodate higher drug prices. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
